Literature DB >> 17263698

Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation.

B Kalender1, A C Ozdemir, E Dervisoglu, O Ozdemir.   

Abstract

In the present study, our aim is to investigate the effects of the treatment modality, depression, malnutrition and inflammation on quality of life (QoL) in chronic kidney disease (CKD). Twenty-six patients with CKD on conservative management, 68 patients on haemodialysis (HD), 47 patients on continuous ambulatory peritoneal dialysis (CAPD) and 66 healthy controls were enrolled in the study. QoL was measured by means of the Short Form-36 (SF-36) and subscale scores were calculated. All patients were evaluated for the presence of depression using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Axis I Disorders - Clinician Version. The severity of depression was evaluated by means of the Beck Depression Inventory (BDI). Serum C-reactive protein (CRP), ferritin, albumin, haemoglobin and haematocrit (Hct) levels were measured. All the SF-36 subscale scores were lower in the patient groups compared with control group. The SF-36 scores were higher and BDI scores were lower in the CAPD group than CKD and HD groups. In patients with depression, all SF-36 subscale scores were lower than that of the patients without depression. There was a significant negative correlation between all the SF-36 subscale scores and the BDI scores. There was a significant positive correlation between the SF-36 physical and total summary scores and the Hct value and serum albumin levels, but an inverse correlation between the SF-36 physical, mental and total summary scores and the serum CRP level in the HD patients. The authors suggest that the treatment modality, depression, malnutrition and inflammation have an important role on QoL in CKD.

Entities:  

Mesh:

Year:  2007        PMID: 17263698     DOI: 10.1111/j.1742-1241.2006.01251.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  34 in total

1.  Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.

Authors:  Michael J Fischer; Paul L Kimmel; Tom Greene; Jennifer J Gassman; Xuelei Wang; Deborah H Brooks; Jeanne Charleston; Donna Dowie; Denyse Thornley-Brown; Lisa A Cooper; Marino A Bruce; John W Kusek; Keith C Norris; James P Lash
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

Review 2.  Measuring the health status burden in hemodialysis patients using the SF-36® health survey.

Authors:  Aaron S Yarlas; Michelle K White; Min Yang; Renee N Saris-Baglama; Peter Galthen Bech; Torsten Christensen
Journal:  Qual Life Res       Date:  2010-10-23       Impact factor: 4.147

3.  C-reactive protein as an available biomarker determining mental component of health-related quality of life among individuals with spinal cord injury.

Authors:  Hadis Sabour; Sahar Latifi; Zahra Soltani; Hania Shakeri; Abbas Norouzi Javidan; Seyed-Mohammad Ghodsi; Mohammad Reza Hadian; Seyed-Hassan Emami Razavi
Journal:  J Spinal Cord Med       Date:  2016-02-25       Impact factor: 1.985

4.  Predictors of health-related quality of life perceived by end-stage renal disease patients under online hemodiafiltration.

Authors:  Alexandra Moura; José Madureira; Pablo Alija; João Carlos Fernandes; José Gerardo Oliveira; Martin Lopez; Madalena Filgueiras; Leonilde Amado; Maria Sameiro-Faria; Vasco Miranda; Edgar Mesquita; Alice Santos-Silva; Elísio Costa
Journal:  Qual Life Res       Date:  2014-11-08       Impact factor: 4.147

5.  Risk factors for depressive symptoms in a large population on chronic hemodialysis.

Authors:  Sônia M H A Araujo; Veralice M S de Bruin; Elizabeth de F Daher; Gilson H Almeida; Camila A M Medeiros; Pedro Felipe C de Bruin
Journal:  Int Urol Nephrol       Date:  2011-07-22       Impact factor: 2.370

6.  Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies.

Authors:  Michael J Fischer; Dawei Xie; Neil Jordan; Willem J Kop; Marie Krousel-Wood; Manjula Kurella Tamura; John W Kusek; Virginia Ford; Leigh K Rosen; Louise Strauss; Valerie L Teal; Kristine Yaffe; Neil R Powe; James P Lash
Journal:  Am J Kidney Dis       Date:  2012-04-11       Impact factor: 8.860

7.  Quality of life and emotional distress between patients on peritoneal dialysis versus community-based hemodialysis.

Authors:  K Griva; A W Kang; Z L Yu; N K Mooppil; M Foo; Choong Meng Chan; S P Newman
Journal:  Qual Life Res       Date:  2013-05-21       Impact factor: 4.147

8.  Sleep quality, mood, alertness and their variability in CKD and ESRD.

Authors:  Maria-Eleni Roumelioti; Christos Argyropoulos; Daniel J Buysse; Harry Nayar; Steven D Weisbord; Mark L Unruh
Journal:  Nephron Clin Pract       Date:  2010-01-20

9.  Depression in patients with chronic kidney disease on dialysis in Saudi Arabia.

Authors:  Faten Al Zaben; Doaa Ahmed Khalifa; Mohammad Gamal Sehlo; Saad Al Shohaib; Faisul Shaheen; Hanadi Alhozali; Alferdose Osama Hariri; Riyadh Ghazi Ahmad; Moayad Reda Kabli; Harold G Koenig
Journal:  Int Urol Nephrol       Date:  2014-08-28       Impact factor: 2.370

10.  Examining the relationship between nutrition, quality of life, and depression in hemodialysis patients.

Authors:  Shawona C Daniel; Andres Azuero; Orlando M Gutierrez; Karen Heaton
Journal:  Qual Life Res       Date:  2020-10-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.